JG
HRMY icon

Joel Greenblatt’s Harmony Biosciences HRMY Stock Holding History

Joel Greenblatt’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.31M Sell
35,866
-28,318
-44% -$893K ﹤0.01% 1291
2026
Q1 		$1.8M Buy
64,184
+32,411
+102% +$1.06M 0.01% 1146
2025
Q4 		$1.19M Sell
31,773
-7,125
-18% -$234K ﹤0.01% 1209
2025
Q3 		$1.07M Sell
38,898
-809
-2% -$27.9K ﹤0.01% 1180
2025
Q2 		$1.25M Buy
39,707
+16,544
+71% +$532K 0.01% 1072
2025
Q1 		$769K Sell
23,163
-27,339
-54% -$980K 0.01% 1084
2024
Q4 		$1.74M Sell
50,502
-16,220
-24% -$557K 0.02% 751
2024
Q3 		$2.67M Sell
66,722
-18,283
-22% -$642K 0.03% 653
2024
Q2 		$2.56M Buy
85,005
+1,277
+2% +$38.4K 0.03% 610
2024
Q1 		$2.81M Buy
83,728
+1,530
+2% +$49.1K 0.04% 545
2023
Q4 		$2.65M Buy
82,198
+18,334
+29% +$512K 0.05% 507
2023
Q3 		$2.09M Sell
63,864
-8,838
-12% -$307K 0.04% 534
2023
Q2 		$2.56M Buy
72,702
+44,969
+162% +$1.55M 0.06% 473
2023
Q1 		$905K Buy
+27,733
New +$1.26M 0.02% 781
2022
Q4 		– Sell
-19,684
Closed -$872K – 1255
2022
Q3 		$872K Buy
+19,684
New +$960K 0.03% 697

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Joel Greenblatt's HRMY Position: Q2 2026 in Review

Joel Greenblatt reduced its Harmony Biosciences (HRMY) stake by 44% in Q2 2026, selling an estimated $893K and leaving 35,866 shares worth $1.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1291.

Joel Greenblatt first reported a position in HRMY in Q3 2022 and has held it in 15 quarters since. The position peaked at $2.81M in Q1 2024. 324 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Joel Greenblatt held 35,866 shares of Harmony Biosciences worth $1.31M as of Q2 2026.
  • Joel Greenblatt sold 28,318 Harmony Biosciences shares in Q2 2026, an estimated $893K.
  • Harmony Biosciences made up ﹤0.01% of Joel Greenblatt's portfolio in Q2 2026, its #1291 holding.
  • Joel Greenblatt first reported a position in Harmony Biosciences in Q3 2022 and has held it in 15 quarters since.
  • Joel Greenblatt's Harmony Biosciences position peaked at $2.81M in Q1 2024.
  • 324 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.